1. Home
  2. USPH vs ABCL Comparison

USPH vs ABCL Comparison

Compare USPH & ABCL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo U.S. Physical Therapy Inc.

USPH

U.S. Physical Therapy Inc.

HOLD

Current Price

$82.44

Market Cap

1.3B

Sector

Health Care

ML Signal

HOLD

Logo AbCellera Biologics Inc.

ABCL

AbCellera Biologics Inc.

HOLD

Current Price

$3.91

Market Cap

1.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
USPH
ABCL
Founded
1990
2012
Country
United States
Canada
Employees
N/A
N/A
Industry
Medical/Nursing Services
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.3B
1.1B
IPO Year
1992
2020

Fundamental Metrics

Financial Performance
Metric
USPH
ABCL
Price
$82.44
$3.91
Analyst Decision
Buy
Buy
Analyst Count
4
5
Target Price
$106.50
$7.75
AVG Volume (30 Days)
213.3K
5.0M
Earning Date
02-25-2026
02-24-2026
Dividend Yield
2.17%
N/A
EPS Growth
153.49
N/A
EPS
2.38
N/A
Revenue
$750,948,000.00
$35,325,000.00
Revenue This Year
$19.53
$25.45
Revenue Next Year
$6.33
$10.07
P/E Ratio
$34.94
N/A
Revenue Growth
17.51
7.17
52 Week Low
$62.77
$1.89
52 Week High
$93.50
$6.52

Technical Indicators

Market Signals
Indicator
USPH
ABCL
Relative Strength Index (RSI) 47.39 46.75
Support Level $84.94 $3.92
Resistance Level $88.69 $4.25
Average True Range (ATR) 3.10 0.31
MACD -0.41 -0.03
Stochastic Oscillator 28.54 5.50

Price Performance

Historical Comparison
USPH
ABCL

About USPH U.S. Physical Therapy Inc.

US Physical Therapy Inc through its subsidiaries operates outpatient physical therapy clinics that provide pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries. The principal payment sources for the clinics' services are managed care programs, commercial health insurance, Medicare/Medicaid, workers' compensation insurance, and proceeds from personal injury cases. Its operating segment includes Physical therapy operations and Industrial injury prevention services. The company generates maximum revenue from the Physical therapy operations segment.

About ABCL AbCellera Biologics Inc.

AbCellera Biologics Inc is an antibody discovery and development engine that's specifically designed to address the barriers of conventional discovery, finding the optimal clinical candidate with greater precision and speed, getting to the clinic and patients sooner. With the integrated AbCellera platform, the company's experts search a wide range of diverse antibodies to select the effective and developable leads fast and set partners up for enduring success. The company has extensive experience forging partnerships with emerging biotechs and pharmaceutical companies. AbCellera leverages proprietary hardware, software, and tools along with the latest data science, to operate as strategic partners and help develop optimized solutions faster for any program.

Share on Social Networks: